← Leaderboards
Dominic Hodgkin
Brandeis University
$6,809,529
Attributed
$8,580,208
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,580,208 · 7
AHRQ$0 · 1
By mechanism
R01$5,796,142 · 6
P30$2,575,565 · 1
R21$208,501 · 1
Top collaborators
- Haiden A. Huskamp4 shared
- Maureen T Stewart1 shared
Most similar at Brandeis University
Same institution · by research overlap
- Maureen T Stewart$6,986,227
- Sharon Reif$14,477,953
- Donald Sloane Shepard$1,620,041
- Thomas I. Mackie$59,035
Others in their field
Top investigators on “Characteristics”
- Lawrence Corey · Fred Hutchinson Cancer Center$259,409,773
- Jeffrey P Krischer · University Of South Florida$234,914,225
- Constance Ann Benson · University Of California, San Diego$187,977,954
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$136,053,061
- Peter B. Gilbert · Fred Hutchinson Cancer Center$118,817,242
Research focus
CharacteristicsProviderPharmaceutical PreparationsPhysiciansCaringBaseDesignPoliciesPharmacotherapyEffectivenessServicesEvidence BaseAreaMental DisordersSpecialistPsychiatristFundingProgramsFutureAffectMedication ComplianceMedicinePerceptionData Set
Grant awards (21)
Examining opioid use disorder treatment in Medicaid managed care plans: policies and outcomes$673,894
R01 · FY2024 · DA · contact PI
Medications for Alcohol Use Disorder:Â Unfilled Prescriptions and Treatment Trajectories$454,219
R01 · FY2024 · AA
Medications for Alcohol Use Disorder:Â Unfilled Prescriptions and Treatment Trajectories$810,009
R01 · FY2023 · AA
Medications for Alcohol Use Disorder:Â Unfilled Prescriptions and Treatment Trajectories$805,819
R01 · FY2022 · AA
Medications for Alcohol Use Disorder:Â Unfilled Prescriptions and Treatment Trajectories$797,418
R01 · FY2021 · AA
Research Support Core$464,870
P30 · FY2019 · DA · contact PI
Research Support Core$551,206
P30 · FY2018 · DA · contact PI
Research Support Core$583,656
P30 · FY2017 · DA · contact PI
Research Support Core$488,648
P30 · FY2016 · DA · contact PI
Research Support Core$487,185
P30 · FY2015 · DA · contact PI
Clinical Inertia in Prescribing for Bipolar Disorder$348,930
R01 · FY2013 · MH · contact PI
Enhancing Early-Phase Care for Primary Care Patients with Unhealthy Substance Use$208,501
R21 · FY2013 · DA · contact PI
Clinical Inertia in Prescribing for Bipolar Disorder$322,083
R01 · FY2012 · MH · contact PI
The Role of Customization in Psychotropic Prescribing$366,866
R01 · FY2009 · MH · contact PI
The Role of Customization in Psychotropic Prescribing$370,030
R01 · FY2008 · MH · contact PI
The Role of Customization in Psychotropic Prescribing$400,791
R01 · FY2007 · MH · contact PI
Specialty Mental Health Care--Expanding Access in an HMO$74,549
R01 · FY2003 · MH
Impact of 3 Tier Drug Copays on Use and Spending$0
R01 · FY2003 · HS
Specialty Mental Health Care--Expanding Access in an HMO$149,325
R01 · FY2002 · MH
Impact of 3 Tier Drug Copays on Use and Spending$0
R01 · FY2002 · HS
Specialty Mental Health Care--Expanding Access in an HMO$222,209
R01 · FY2001 · MH